Celosia (Celosia argentea)

Celosia argentea is a TCM herb whose bioactive compounds — including flavonoids, saponins, and kaempferol glycosides — exert antioxidant, anti-inflammatory, and hypoglycemic effects. These compounds act through free radical scavenging and modulation of inflammatory mediators, supporting its traditional use in treating eye disorders, inflammation, and metabolic conditions.

Origin & History

Celosia argentea, also known as cockscomb, is an annual herbaceous plant native to tropical regions of Africa, Asia, and South America. It is often grown as a weed or ornamental plant during the rainy season, with extracts prepared from its leaves, seeds, and flowers using various solvents.

Historical & Cultural Context

Celosia argentea has been used in Indian traditional medicine for conditions such as inflammatory disorders, eye health, and blood sugar management. It is recognized for its general therapeutic properties and has a longstanding history in global herbal traditions.

Health Benefits

• Potential to reduce blood glucose levels in diabetic rats, as shown by a study involving methanolic leaf extract (p<0.05)[4]. • Exhibits antioxidative effects, demonstrated by DPPH scavenging up to 91.26% and ABTS inhibition up to 89.29% in cell cultures[3]. • Anti-inflammatory properties supported by inhibition of LPS-induced nitric oxide in macrophages[1][2]. • Anticancer effects in vitro, inducing apoptosis in HT-29 and MCF-7 cells[5]. • Traditionally used to manage hyperglycemia and inflammation, though clinical evidence is limited[1][2][5].

How It Works

Celosia argentea's flavonoids and phenolic compounds donate hydrogen atoms to neutralize free radicals, achieving DPPH scavenging up to 91.26% and ABTS inhibition up to 89.29%, likely via electron transfer from hydroxyl groups on kaempferol and quercetin derivatives. Its saponins and terpenoids suppress pro-inflammatory cytokines such as TNF-α and IL-6, potentially through inhibition of the NF-κB signaling pathway. The hypoglycemic effect observed in diabetic rat models may involve inhibition of α-glucosidase and α-amylase enzymes, slowing carbohydrate digestion and reducing postprandial glucose spikes.

Scientific Research

No human clinical trials or meta-analyses specifically on Celosia argentea were identified in the research dossier. Preclinical studies include effects on diabetic rats and anti-inflammatory assays in cell cultures. A referenced RCT on seeds for type 2 diabetes management lacks detailed information (PMID 41778911).

Clinical Summary

Current evidence for Celosia argentea is largely preclinical, drawn from in vitro cell culture assays and animal models rather than human clinical trials. A study using methanolic leaf extract in streptozotocin-induced diabetic rats demonstrated a statistically significant reduction in blood glucose levels (p<0.05), suggesting antidiabetic potential. Antioxidant activity was quantified in cell culture with DPPH scavenging reaching 91.26% and ABTS inhibition reaching 89.29% at tested concentrations. Anti-inflammatory properties have also been supported in laboratory settings, but the absence of randomized controlled trials in humans means evidence strength remains preliminary and insufficient for clinical recommendations.

Nutritional Profile

Celosia argentea contains a range of macronutrients, micronutrients, and bioactive compounds, though comprehensive quantitative data remains limited in standardized databases. Leaves are reported to contain approximately 3.5–5.2g protein per 100g fresh weight, with dietary fiber content estimated at 2–4g per 100g. Fat content is low, typically <1g per 100g. Carbohydrates constitute the majority of dry weight. Key micronutrients include calcium (reported at ~400–800mg per 100g dry weight in some African food composition studies), iron (~15–25mg per 100g dry weight), potassium, magnesium, and zinc at moderate levels. Vitamin C content has been reported in the range of 30–60mg per 100g fresh leaf. Beta-carotene (provitamin A) is present as a major pigment contributor. Bioactive compounds include: betacyanins and betaxanthins (betalain pigments, primary antioxidant contributors), kaempferol and its glycosides, quercetin derivatives, rutin, and luteolin as predominant flavonoids. Triterpenoid saponins including oleanolic acid and its derivatives have been isolated. Phytosterols including beta-sitosterol are present. Seeds contain fixed oils with linoleic acid as a dominant fatty acid (~50–60% of seed oil fatty acid profile). Alkaloids including celosian have been identified. Polysaccharides from seeds (notably celosian polysaccharides) are documented immunomodulatory compounds. Bioavailability of iron may be limited by co-occurring oxalates and phytates; cooking reduces antinutritional factors. Betalain bioavailability is moderate and condition-dependent.

Preparation & Dosage

No clinically studied dosages in humans are available. In animal models, methanolic leaf extract was dosed at 250-750 mg/kg body weight daily for 3 weeks. In vitro studies used concentrations of 50-200 μg/mL. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Turmeric, Cinnamon, Green Tea, Black Pepper, Ginger

Safety & Interactions

Celosia argentea has a long history of use in TCM and as a food plant in Africa and Asia, suggesting general tolerability at culinary doses, but formal human safety trials are lacking. Because preclinical data indicates blood glucose-lowering activity, concurrent use with antidiabetic medications such as metformin or insulin may theoretically produce additive hypoglycemic effects, warranting caution and monitoring. No well-documented drug interaction data exists in the clinical literature, and safety during pregnancy or lactation has not been established, so use should be avoided in these populations without medical supervision. Individuals with hypotension should also exercise caution given the herb's reported vasodilatory properties in some animal studies.